Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lacosamide Open-Label Extension in Partial Seizures
NCT00522275Phase 3Completed
- Sponsor
- UCB
- Start
- Oct 2004
- Primary completion
- Oct 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of lacosamide in focal seizures, sponsored by UCB. Started Oct 2004; status: completed.
02
Drugs
lacosamide
03
Conditions
focal seizures
Beyond the preview
Go deeper on NCT00522275.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00522275.